| Literature DB >> 31542241 |
Sandra Angélica Rojas-Osornio1, Teresita Rocío Cruz-Hernández1, Maria Elisa Drago-Serrano2, Rafael Campos-Rodríguez3.
Abstract
Obesity is a health concern that is recognized as a critical factor for vulnerability to influenza A/pdmH1N1 virus infection, with epidemiological and clinical impacts. In humans, obesity induces disturbances in inflammatory and immune responses to the influenza virus and in some cases, this leads to severe complications, with fatal outcomes. Obesity impairs immunity by altering the response of cytokines, resulting in a decrease in the cytotoxic cell response of immunocompetent cells which have a key anti-viral role. Additionally, obesity seems to disturb the balance of endocrine hormones, such as leptin, that affect the interplay between metabolic and immune systems. This contribution focuses on reviewing the current epidemiologic data for the immune response to immunity in obese humans and animal models. In doing so, we aim to provide potential mechanisms to enhance immunity to influenza A/pdmH1N1 virus infection and protective factors in obese people.Entities:
Keywords: Influenza A/pdmH1N1 virus; Leptin; Obesity; Vaccine
Year: 2019 PMID: 31542241 DOI: 10.1016/j.orcp.2019.05.003
Source DB: PubMed Journal: Obes Res Clin Pract ISSN: 1871-403X Impact factor: 2.288